Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IM Cannabis Corp - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
IMCC
New York
2833
https://imcannabis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IM Cannabis Corp
IMC to transfer its Oranim Pharmacy shares back to the seller
- Apr 16th, 2024 12:00 pm
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
- Apr 9th, 2024 12:40 pm
Avant and IMC Execute BLK MKTā¢ Trademark Licensing Agreement for the German Medical Cannabis Market
- Apr 4th, 2024 11:30 am
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
- Apr 4th, 2024 11:30 am
IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients
- Apr 1st, 2024 12:30 pm
IM Cannabis Reports 2023 Financial Results
- Mar 28th, 2024 12:56 pm
IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization
- Mar 25th, 2024 12:00 pm
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
- Mar 20th, 2024 11:00 am
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company
- Feb 28th, 2024 2:00 pm
IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule
- Jan 31st, 2024 12:00 pm
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
- Jan 12th, 2024 12:00 pm
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
- Jan 2nd, 2024 12:00 pm
New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023
- Dec 8th, 2023 12:00 pm
IM Cannabis Announces Receipt of Court Action
- Nov 27th, 2023 12:00 pm
IM Cannabis Reports Third Quarter 2023 Financial Results
- Nov 13th, 2023 1:00 pm
IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET
- Nov 8th, 2023 12:00 pm
IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt
- Oct 13th, 2023 11:00 am
IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer
- Oct 10th, 2023 11:00 am
IM Cannabis Announces CFO Departure
- Sep 19th, 2023 11:00 am
The 3 Best Cannabis Stocks to Buy Now: September 2023
- Sep 10th, 2023 8:11 pm
Scroll